STAT Plus: Pharmalittle: Trump’s ‘Buy American’ order raises doubts; Gilead looks to boost global remdesivir output

And so, another working week will soon draw to a close. Not a moment too soon, yes? This is, you may recall, our treasured signal to daydream about weekend plans. Given the circumstances, our agenda is rather modest. We plan to gaze at the telly now and then, promenade with the official mascot, putter around the castle, and catch up on our reading. And what about you? This remains a fine time to appreciate the great outdoors. Perhaps a drive-in movie is a possibility. Or you may want to reach out to someone feeling a bit isolated these days. Well, whatever you do, have a grand time. But be safe — wear a mask. Enjoy, and see you soon. …

President Trump signed an executive order Thursday directing the federal government to buy certain drugs solely from American factories, STAT reports. The “Buy American” order could represent a seismic shakeup of the pharmaceutical industry. No one knows exactly how much of the American supply chain is produced abroad, but some experts insist up to 90% of critical generic drugs are made at least partially abroad. It remains unclear, however, how broadly the order will be implemented — the executive order does not specify what drugs it covers.

Continue to STAT Plus to read the full story…

Read Original Article: STAT Plus: Pharmalittle: Trump’s ‘Buy American’ order raises doubts; Gilead looks to boost global remdesivir output »